CORONARY THROMBOLYSIS - PHARMACOLOGICAL CONSIDERATIONS WITH EMPHASIS ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA)

被引：23
作者：
FOX, KAA [1 ]
BERGMANN, SR [1 ]
SOBEL, BE [1 ]
机构：
[1] WASHINGTON UNIV,SCH MED,DIV CARDIOVASC,ST LOUIS,MO 63110
来源：
BIOCHEMICAL PHARMACOLOGY | 1984年 / 33卷 / 12期
关键词：
D O I：
10.1016/0006-2952(84)90536-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1831 / 1838
页数：8
相关论文
共 67 条
[1]  
ASTRUP T, 1966, FED PROC, V25, P42
[2]   SUPRAOPTIC NEUROSECRETORY CELLS - ADRENERGIC AND CHOLINERGIC SENSITIVITY [J].
BARKER, JL .
SCIENCE, 1971, 171 (3967) :208-+
[3]   BIOCHEMICAL-COMPARISON OF INTERMITTENT STREPTOKINASE AND INTERMITTENT STREPTOKINASE PLASMINOGEN THERAPY [J].
BARLOW, GH ;
KAKKAR, VV ;
BENTLEY, PG ;
CHAN, PS ;
JONES, NAG ;
MISTRY, FD .
THROMBOSIS RESEARCH, 1979, 15 (1-2) :135-142
[4]   TEMPORAL DEPENDENCE OF BENEFICIAL-EFFECTS OF CORONARY THROMBOLYSIS CHARACTERIZED BY POSITRON TOMOGRAPHY [J].
BERGMANN, SR ;
LERCH, RA ;
FOX, KAA ;
LUDBROOK, PA ;
WELCH, MJ ;
TERPOGOSSIAN, MM ;
SOBEL, BE .
AMERICAN JOURNAL OF MEDICINE, 1982, 73 (04) :573-581
[5]  
BERGMANN SR, 1983, SCIENCE, V220, P1181
[6]  
BOWIE EJW, 1982, THROMBOLYSIS, P7
[7]   STREPTOKINASE - REVIEW OF ITS CLINICAL PHARMACOLOGY, MECHANISM OF ACTION AND THERAPEUTIC USES [J].
BROGDEN, RN ;
SPEIGHT, TM ;
AVERY, GS .
DRUGS, 1973, 5 (5-6) :357-445
[8]   SHORT-TERM ENHANCEMENT OF PLASMINOGEN ACTIVATOR INVIVO BY DRUGS [J].
CASH, JD .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (03) :648-651
[9]  
CASH JD, 1975, PROGR CHEM FIBRINOLY, V1, P97
[10]  
CASH JD, 1978, PROGR CHEM FIBRINOLY, V3, P65
1234567